HEADER LIPID BINDING PROTEIN 21-APR-06 2DMG TITLE SOLUTION STRUCTURE OF THE THIRD C2 DOMAIN OF KIAA1228 PROTEIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: KIAA1228 PROTEIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: C2 DOMAIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: KIAA1228; SOURCE 6 EXPRESSION_SYSTEM: CELL FREE SYNTHESIS; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: P050627-28; SOURCE 9 OTHER_DETAILS: CELL-FREE PROTEIN SYNTHESIS KEYWDS BETA-SANDWICH, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON KEYWDS 2 PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL KEYWDS 3 GENOMICS/PROTEOMICS INITIATIVE, RSGI, LIPID BINDING PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR T.NAGASHIMA,F.HAYASHI,S.YOKOYAMA,RIKEN STRUCTURAL GENOMICS/PROTEOMICS AUTHOR 2 INITIATIVE (RSGI) REVDAT 4 29-MAY-24 2DMG 1 REMARK REVDAT 3 09-MAR-22 2DMG 1 REMARK SEQADV REVDAT 2 24-FEB-09 2DMG 1 VERSN REVDAT 1 21-OCT-06 2DMG 0 JRNL AUTH T.NAGASHIMA,F.HAYASHI,S.YOKOYAMA JRNL TITL SOLUTION STRUCTURE OF THE THIRD C2 DOMAIN OF KIAA1228 JRNL TITL 2 PROTEIN JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : VNMR 6.1C, CYANA 2.0.17 REMARK 3 AUTHORS : VARIAN (VNMR), GUNTERT, P. (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2DMG COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 24-APR-06. REMARK 100 THE DEPOSITION ID IS D_1000025587. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 293 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 120MM REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.76MM UNIFORMLY 13C AND 15N REMARK 210 LABELED PROTEIN; 20MM TRISHCL, REMARK 210 100MM NACL, 1MM DTT, 0.02% NAN3, REMARK 210 10% D2O, 90% H2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_15N-SEPARATED_NOESY; 3D_13C REMARK 210 -SEPARATED_NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE 20020425, NMRVIEW 5.0.4, REMARK 210 KUJIRA 0.9318, CYANA 2.0.17 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION, STRUCTURES WITH REMARK 210 THE LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 HIS A 31 -74.64 -46.60 REMARK 500 1 ASP A 55 119.85 -36.57 REMARK 500 1 ARG A 57 136.49 -35.43 REMARK 500 1 SER A 82 91.27 -69.62 REMARK 500 1 SER A 100 47.42 -80.00 REMARK 500 1 SER A 105 -52.85 -132.79 REMARK 500 1 LYS A 106 36.94 71.21 REMARK 500 1 GLU A 122 37.29 -83.55 REMARK 500 1 SER A 137 100.19 -40.70 REMARK 500 1 SER A 140 78.00 -108.51 REMARK 500 2 SER A 2 172.88 -48.73 REMARK 500 2 VAL A 30 77.61 -114.76 REMARK 500 2 HIS A 31 -73.07 -44.16 REMARK 500 2 ILE A 37 151.39 -45.96 REMARK 500 2 ASP A 55 109.37 -35.88 REMARK 500 2 SER A 82 91.07 -68.75 REMARK 500 2 SER A 140 98.33 -54.31 REMARK 500 3 SER A 5 -53.45 -131.03 REMARK 500 3 VAL A 30 77.88 -105.91 REMARK 500 3 HIS A 31 -74.56 -41.11 REMARK 500 3 ASP A 55 127.57 -34.37 REMARK 500 3 ASN A 72 77.05 -110.38 REMARK 500 3 GLU A 122 47.98 -106.66 REMARK 500 3 ALA A 124 -36.32 -37.17 REMARK 500 3 SER A 137 152.36 -44.25 REMARK 500 4 HIS A 31 -75.08 -48.55 REMARK 500 4 ASP A 55 103.71 -33.86 REMARK 500 4 ARG A 58 35.88 34.05 REMARK 500 4 SER A 59 -70.03 -111.81 REMARK 500 4 SER A 82 91.79 -68.02 REMARK 500 4 ASP A 107 106.98 -52.45 REMARK 500 4 GLU A 122 47.55 -97.88 REMARK 500 4 ALA A 124 -36.96 -34.06 REMARK 500 4 PRO A 139 -179.47 -69.74 REMARK 500 5 HIS A 31 -73.45 -54.64 REMARK 500 5 ASP A 55 97.40 -44.37 REMARK 500 5 ASN A 72 78.72 -113.02 REMARK 500 5 SER A 82 90.08 -68.42 REMARK 500 5 ARG A 91 -178.10 -66.18 REMARK 500 5 SER A 100 107.78 -47.34 REMARK 500 5 ASP A 107 -175.55 -67.70 REMARK 500 6 SER A 2 51.31 34.85 REMARK 500 6 VAL A 30 77.72 -118.21 REMARK 500 6 HIS A 31 -74.56 -42.73 REMARK 500 6 ASN A 35 51.43 71.62 REMARK 500 6 ILE A 37 132.47 -38.74 REMARK 500 6 GLU A 41 32.70 39.68 REMARK 500 6 PRO A 73 -175.03 -69.80 REMARK 500 6 PHE A 75 -50.68 -125.08 REMARK 500 6 SER A 100 81.05 -57.70 REMARK 500 REMARK 500 THIS ENTRY HAS 164 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: HSK002201202.1 RELATED DB: TARGETDB DBREF 2DMG A 8 136 UNP Q6UKI4 Q6UKI4_HUMAN 757 885 SEQADV 2DMG GLY A 1 UNP Q6UKI4 CLONING ARTIFACT SEQADV 2DMG SER A 2 UNP Q6UKI4 CLONING ARTIFACT SEQADV 2DMG SER A 3 UNP Q6UKI4 CLONING ARTIFACT SEQADV 2DMG GLY A 4 UNP Q6UKI4 CLONING ARTIFACT SEQADV 2DMG SER A 5 UNP Q6UKI4 CLONING ARTIFACT SEQADV 2DMG SER A 6 UNP Q6UKI4 CLONING ARTIFACT SEQADV 2DMG GLY A 7 UNP Q6UKI4 CLONING ARTIFACT SEQADV 2DMG SER A 137 UNP Q6UKI4 CLONING ARTIFACT SEQADV 2DMG GLY A 138 UNP Q6UKI4 CLONING ARTIFACT SEQADV 2DMG PRO A 139 UNP Q6UKI4 CLONING ARTIFACT SEQADV 2DMG SER A 140 UNP Q6UKI4 CLONING ARTIFACT SEQADV 2DMG SER A 141 UNP Q6UKI4 CLONING ARTIFACT SEQADV 2DMG GLY A 142 UNP Q6UKI4 CLONING ARTIFACT SEQRES 1 A 142 GLY SER SER GLY SER SER GLY SER PRO LEU GLY GLN ILE SEQRES 2 A 142 GLN LEU THR ILE ARG HIS SER SER GLN ARG ASN LYS LEU SEQRES 3 A 142 ILE VAL VAL VAL HIS ALA CYS ARG ASN LEU ILE ALA PHE SEQRES 4 A 142 SER GLU ASP GLY SER ASP PRO TYR VAL ARG MET TYR LEU SEQRES 5 A 142 LEU PRO ASP LYS ARG ARG SER GLY ARG ARG LYS THR HIS SEQRES 6 A 142 VAL SER LYS LYS THR LEU ASN PRO VAL PHE ASP GLN SER SEQRES 7 A 142 PHE ASP PHE SER VAL SER LEU PRO GLU VAL GLN ARG ARG SEQRES 8 A 142 THR LEU ASP VAL ALA VAL LYS ASN SER GLY GLY PHE LEU SEQRES 9 A 142 SER LYS ASP LYS GLY LEU LEU GLY LYS VAL LEU VAL ALA SEQRES 10 A 142 LEU ALA SER GLU GLU LEU ALA LYS GLY TRP THR GLN TRP SEQRES 11 A 142 TYR ASP LEU THR GLU ASP SER GLY PRO SER SER GLY HELIX 1 1 SER A 84 ARG A 91 1 8 SHEET 1 A 3 GLN A 12 SER A 20 0 SHEET 2 A 3 LYS A 25 ARG A 34 -1 O ILE A 27 N ARG A 18 SHEET 3 A 3 VAL A 74 PHE A 81 -1 O PHE A 79 N VAL A 28 SHEET 1 B 4 ARG A 62 LYS A 63 0 SHEET 2 B 4 PRO A 46 LEU A 53 -1 N MET A 50 O ARG A 62 SHEET 3 B 4 THR A 92 ASN A 99 -1 O THR A 92 N LEU A 53 SHEET 4 B 4 GLY A 112 ALA A 117 -1 O GLY A 112 N VAL A 97 CISPEP 1 LEU A 53 PRO A 54 1 -0.10 CISPEP 2 LEU A 53 PRO A 54 2 -0.15 CISPEP 3 LEU A 53 PRO A 54 3 -0.08 CISPEP 4 LEU A 53 PRO A 54 4 -0.08 CISPEP 5 LEU A 53 PRO A 54 5 -0.15 CISPEP 6 LEU A 53 PRO A 54 6 -0.21 CISPEP 7 LEU A 53 PRO A 54 7 -0.13 CISPEP 8 LEU A 53 PRO A 54 8 -0.15 CISPEP 9 LEU A 53 PRO A 54 9 -0.19 CISPEP 10 LEU A 53 PRO A 54 10 -0.16 CISPEP 11 LEU A 53 PRO A 54 11 -0.14 CISPEP 12 LEU A 53 PRO A 54 12 -0.08 CISPEP 13 LEU A 53 PRO A 54 13 -0.15 CISPEP 14 LEU A 53 PRO A 54 14 -0.13 CISPEP 15 LEU A 53 PRO A 54 15 -0.09 CISPEP 16 LEU A 53 PRO A 54 16 -0.10 CISPEP 17 LEU A 53 PRO A 54 17 -0.13 CISPEP 18 LEU A 53 PRO A 54 18 -0.19 CISPEP 19 LEU A 53 PRO A 54 19 -0.15 CISPEP 20 LEU A 53 PRO A 54 20 -0.10 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1